|Preferred IUPAC name
|Systematic IUPAC name
|Jmol interactive 3D||Image|
|Molar mass||156.23 g·mol−1|
|Density||0.944 g cm−3|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
4-Hydroxynonenal, or 4-hydroxy-2-nonenal or 4-HNE or HNE, (C9H16O2), is an α,β-unsaturated hydroxyalkenal that is produced by lipid peroxidation in cells. 4-HNE is the primary alpha,beta-unsaturated hydroxyalkenal formed in this process.
4-HNE has 3 reactive groups: an aldehyde, a double-bond at carbon 2, and a hydroxy group at carbon 4.
The first characterization of 4-hydroxynonenal was reported by Esterbauer, et al. in 1991, and since then the amount of research involving this chemical has been steadily increasing, with entire issues of relatively high-impact journals such as Molecular Aspects of Medicine and Free Radical Biology and Medicine devoting volumes to 4-HNE-centered publications.
4-Hydroxynonenal is generated in the oxidation of lipids containing polyunsaturated omega-6 acyl groups, such as arachidonic or linoleic groups, and of the corresponding fatty acids viz., the hydroperoxy precursors to 15-hydroxyicosatetraenoic acid and 13-Hydroxyoctadecadienoic acid, respectively. Although they are the most studied ones, in the same process other oxygenated α,β-unsaturated aldehydes (OαβUAs) are generated also, which can also come from omega-3 fatty acids, such as 4-oxo-trans-2-nonenal, 4-hydroxy-trans-2-hexenal, 4-hydroperoxy-trans-2-nonenal and 4,5-epoxy-trans-2-decenal
These compounds can be produced in cells and tissues of living organisms or in foods during processing or storage, and from these latter can be absorbed through the diet. Since 1991, OαβUAs are receiving a great deal of attention because they are being considered as possible causal agents of numerous diseases, such as chronic inflammation, neurodegenerative diseases, adult respiratory distress syndrome, atherogenesis, diabetes and different types of cancer.
There seems to be a dual and hormetic action of 4-HNE on the health of cells: lower intracellular concentrations (around 0.1-5 micromolar) seem to be beneficial to cells, promoting proliferation, differentiation, antioxidant defense and compensatory mechanism, while higher concentrations (around 10-20 micromolar) have been shown to trigger well-known toxic pathways such as the induction of caspase enzymes, the laddering of genomic DNA, the release of cytochrome c from mitochondria, with the eventual outcome of cell death (through both apoptosis and necrosis, depending on concentration). HNE has been linked in the pathology of several diseases such as Alzheimer's disease, cataract, atherosclerosis, diabetes and cancer.
The increasing trend to enrich foods with polyunsaturated acyl groups entails the potential risk of enriching the food with some OαβUAs at the same time, as has already been detected in some studies carried out in 2007. PUFA-fortified foods available on the market have been increasing since epidemiological and clinical researches have revealed possible effects of PUFA on brain development and curative and/or preventive effects on cardiovascular disease. However, PUFA are very labile and easily oxidizable, thus the maximum beneficial effects of PUFA supplements may not be obtained if they contain significant amounts of toxic OαβUAs, which as commented on above, are being considered as possible causal agents of numerous diseases.
Special attention must also be paid to cooking oils used repeatedly in caterings and households, because in those processes very high amounts of OαβUAs are generated and they can be easily absorbed through the diet.
A small group of enzymes are specifically suited to the detoxification and removal of 4-HNE from cells. Within this group are the glutathione S-transferases (GSTs) such as hGSTA4-4 and hGST5.8, aldose reductase, and aldehyde dehydrogenase. These enzymes have low Km values for HNE catalysis and together are very efficient at controlling the intracellular concentration, up to a critical threshold amount, at which these enzymes are overwhelmed and cell death is inevitable.
Glutathione S-transferases hGSTA4-4 and hGST5.8 catalyze the conjugation of glutathione peptides to 4-hydroxynonenal through a conjugate addition to the alpha-beta unsaturated carbonyl, forming a more water-soluble molecule, GS-HNE. While there are other GSTs capable of this conjugation reaction (notably in the alpha class), these other isoforms are much less efficient and their production is not induced by the stress events which cause the formation of 4-HNE (such as exposure to hydrogen peroxide, ultraviolet light, heat shock, cancer drugs, etc.), as the production of the more specific two isoforms is. This result strongly suggests that hGSTA4-4 and hGST5.8 are specifically adapted by human cells for the purpose of detoxifying 4-HNE to abrogate the downstream effects which such a buildup would cause.
Increased activity of the mitochondrial enzyme aldehyde dehydrogenase 2 (ALDH2) has been shown to have a protective effect against cardiac ischemia in animal models, and the postulated mechanism given by the investigators was 4-hydroxynonenal metabolism.
GS-HNE is a potent inhibitor of the activity of glutathione S-transferase, and therefore must be shuttled out of the cell to allow conjugation to occur at a physiological rate. Ral-interacting GTPase activating protein (RLIP76, also known as Ral-binding protein 1), is a membrane-bound protein which has high activity towards the transport of GS-HNE from the cytoplasm to the extracellular space. This protein accounts for approximately 70% of such transport in human cell lines, while the remainder appears to be accounted for by Multidrug Resistance Protein 1 (MRP1).
- "AC1L1C0X - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 25 March 2005. Identification and Related Records. Retrieved 13 October 2011.
- Awasthi, Y. C.; Yang, Y.; Tiwari, N. K.; Patrick, B.; Sharma, A.; Li, J.; Awasthi, S. (2004). "Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases". Free Radical Biology and Medicine 37 (5): 607–619. doi:10.1016/j.freeradbiomed.2004.05.033. PMID 15288119.
- Esterbauer, H.; Schaur, R. J. R.; Zollner, H. (1991). "Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes". Free Radical Biology and Medicine 11 (1): 81–128. doi:10.1016/0891-5849(91)90192-6. PMID 1937131.
- The August 2003 number of the journal Molecular Aspects of Medicine was entirely dedicated to 4-hydroxy-trans-2-nonenal.
- Am J Physiol Endocrinol Metab. 2010 Dec;299(6):E879-86. doi: 10.1152/ajpendo.00508.2010
- Guillén, M. A. D.; Cabo, N.; Ibargoitia, M. A. L.; Ruiz, A. (2005). "Study of both Sunflower Oil and Its Headspace throughout the Oxidation Process. Occurrence in the Headspace of Toxic Oxygenated Aldehydes". Journal of Agricultural and Food Chemistry 53 (4): 1093–1101. doi:10.1021/jf0489062. PMID 15713025.
- Zanardi, E.; Jagersma, C. G.; Ghidini, S.; Chizzolini, R. (2002). "Solid Phase Extraction and Liquid Chromatography−Tandem Mass Spectrometry for the Evaluation of 4-Hydroxy-2-nonenal in Pork Products". Journal of Agricultural and Food Chemistry 50 (19): 5268–5272. doi:10.1021/jf020201h. PMID 12207460.
- Zarkovic, N. (2003). "4-Hydroxynonenal as a bioactive marker of pathophysiological processes". Molecular Aspects of Medicine 24 (4–5): 281–291. doi:10.1016/S0098-2997(03)00023-2. PMID 12893006.
- Negre-Salvayre, A.; Auge, N.; Ayala, V.; Basaga, H.; Boada, J.; Brenke, R.; Chapple, S.; Cohen, G.; Feher, J.; Grune, T.; Lengyel, G.; Mann, G. E.; Pamplona, R.; Poli, G.; Portero-Otin, M.; Riahi, Y.; Salvayre, R.; Sasson, S.; Serrano, J.; Shamni, O.; Siems, W.; Siow, R. C. M.; Wiswedel, I.; Zarkovic, K.; Zarkovic, N. (2010). "Pathological aspects of lipid peroxidation". Free Radical Research 44 (10): 1125–1171. doi:10.3109/10715762.2010.498478. PMID 20836660.
- Surh, J.; Lee, S.; Kwon, H. (2007). "4-Hydroxy-2-alkenals in polyunsaturated fatty acids-fortified infant formulas and other commercial food products". Food Additives & Contaminants 24 (11): 1209. doi:10.1080/02652030701422465.
- Seppanen, C. M.; Csallany, A. S. (2006). "The effect of intermittent and continuous heating of soybean oil at frying temperature on the formation of 4-hydroxy-2-trans-nonenal and other α-, β-unsaturated hydroxyaldehydes". Journal of the American Oil Chemists' Society 83 (2): 121. doi:10.1007/s11746-006-1184-0.
- Chen, C. -H.; Budas, G. R.; Churchill, E. N.; Disatnik, M. -H.; Hurley, T. D.; Mochly-Rosen, D. (2008). "An Activator of Mutant and Wildtype Aldehyde Dehydrogenase Reduces Ischemic Damage to the Heart". Science 321 (5895): 1493–1495. doi:10.1126/science.1158554. PMC 2741612. PMID 18787169.
- Žarković, N.; Zarković, K.; Schaur, R. J. R.; Stolc, S.; Schlag, G. N.; Redl, H.; Waeg, G.; Borović, S.; Loncarić, I.; Jurić, G.; Hlavka, V. (1999). "4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor". Life Sciences 65 (18–19): 1901–1904. doi:10.1016/S0024-3205(99)00444-0. PMID 10576434.
- Sharma, R.; Brown, D.; Awasthi, S.; Yang, Y.; Sharma, A.; Patrick, B.; Saini, M. K.; Singh, S. P.; Zimniak, P.; Singh, S. V.; Awasthi, Y. C. (2004). "Transfection with 4-hydroxynonenal-metabolizing glutathione S-transferase isozymes leads to phenotypic transformation and immortalization of adherent cells". European Journal of Biochemistry 271 (9): 1690–1701. doi:10.1111/j.1432-1033.2004.04067.x. PMID 15096208.
-  - A biology group devoted to research centered around 4-hydroxynonenal